Abbott Cleared the First Dual Glucose and Ketone Sensor. FDA Judged Accuracy, Not Admissions.
The label says diabetes. The clinical argument is type 1. Coverage conversations start from 2.1 million people, not 40.1 million.
DealPulse Signal
The Beats
Analysis
The Briefs
Abbott Cleared the First Dual Glucose and Ketone Sensor. FDA Judged Accuracy, Not Admissions.
This Money Buys Equipment, Not Operations. Your 2031 Answer Decides the 2027 Deal.
Three Proteins Flip the Tumour Sphere. Blocking Two of Them Flips It Back Toward Chemo-Resistance.
Evernorth Adopts LOCUS in Three States, and States That the Review Process Is Not Changing
A Jury Convicted the Philips Engineer. The Approach Came as His Plant Was Closing.